A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis

Clinical trial NCT01554982 · COMPLETED

Trial details

NCT number: NCT01554982
Sponsor: Keryx Biopharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

End Stage Renal Disease Kidney Failure Renal Failure Hyperphosphatemia ESRD

Start date: 2012-08-01
Primary completion: 2014-06-01
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.